Red Raspberry Leaf in Pregnancy and Labour

If you are reading this at 34 weeks with a box of pregnancy tea on the counter, here is the whole answer before the detail: no clear benefit has been demonstrated for raspberry leaf in labour, and the small amount of clinical work that exists is reassuring rather than conclusive on safety. It is not an induction method. It will very probably not do you any harm in the third trimester if your pregnancy is straightforward. It also may well not do anything at all.

That is an unsatisfying answer, and it is the true one. This page explains where it comes from: what the tradition claims, what the laboratory found (and why the laboratory findings contradict each other), what the two Australian studies actually measured, what the systematic reviews concluded, and where the genuine cautions lie. It is written for the person drinking the tea, not for a journal club — but it does not round the numbers in the tea’s favour to be encouraging.

The Claim, Stated Precisely
What “Uterine Tonic” Means, and Why It Resists Testing
The Laboratory Contradiction: Relaxant and Stimulant
The 1999 Retrospective Study
The 2001 Randomized Double-Blind Trial
What the Systematic Reviews Concluded
It Is Not a Labour Induction Method
Safety in Pregnancy: Known, Assumed, and Unknown
Animal Data and the Offspring Question
If You Are Going to Drink It Anyway
Evidence Tiers at a Glance
Key Research Papers
Connections

The Claim, Stated Precisely

Vagueness is how weak claims survive, so it is worth writing the traditional claim out in the strongest specific form anyone actually makes it. Raspberry leaf, taken as a tea from roughly the eighth month of pregnancy, is said to:

“Tone” the uterine muscle so that contractions in labour are better coordinated and more effective;
shorten labour, particularly the pushing stage;
reduce the need for intervention — fewer forceps, fewer ventouse deliveries, fewer caesareans;
reduce bleeding after birth, on the theory that a well-toned uterus clamps down better;
and, in the folk version that circulates online rather than in midwifery texts, bring labour on when a pregnancy has gone past its date.

Claim 5 has no support at all and is dealt with below. Claims 1 through 4 have been tested exactly once in a randomized trial, in one country, by one research group, in roughly 190 women. Everything written about raspberry leaf and labour in the last quarter-century rests on that single trial plus one earlier look-back study by the same team.

What “Uterine Tonic” Means, and Why It Resists Testing

“Tonic” is one of the oldest words in herbal medicine and one of the least testable. A tonic is not supposed to produce an event you can time; it is supposed to condition a tissue gradually so that when the tissue is called on, it performs better. Applied to the uterus, that means raspberry leaf is not claimed to cause a contraction — it is claimed to improve the quality of contractions that happen weeks later.

Notice what that does to the burden of proof. A herb that starts contractions can be tested in an afternoon. A herb that makes future contractions subtly better needs a trial that randomizes women months in advance, keeps them blinded, and then measures something as messy and multi-causal as the length of a labour — which depends on parity, fetal position, epidural use, maternal age, induction, obstetric practice on the day, and a dozen other things that swamp a small effect.

This matters for interpreting the evidence honestly in both directions. It is why the existing trial was probably too small to detect a modest real effect if one existed — and equally why a promising-looking secondary result in a trial of that size cannot be taken at face value. The uterus is also physiologically unusual: it changes receptor expression, gap-junction coupling and oxytocin sensitivity dramatically across late pregnancy, so a compound’s effect on non-pregnant tissue in a dish may bear no relation to its effect at term.

The Laboratory Contradiction: Relaxant and Stimulant

Evidence tier: preliminary (in vitro and animal).

The mechanism story usually names fragarine, an alkaloid found in Rubus and Fragaria (strawberry) leaves, and says it “tones” the uterus. Follow that claim back to its sources and it splits in half.

In 1941 The Lancet published Burn and Withell’s report of a principle in raspberry leaves that relaxed uterine muscle. In the same year the British Medical Journal carried Whitehouse’s description of fragarine as an inhibitor of uterine action. Both of those are relaxant findings — the opposite of “strengthens contractions.” Then in 1970 the British Journal of Pharmacology published work by Bamford and colleagues on raspberry leaf and uterine smooth muscle which found that the direction of the effect was not fixed: depending on the preparation and on whether the tissue was quiescent or already contracting, the extract could stimulate or could inhibit. A 2002 Phytotherapy Research study of Rubus idaeus leaf extract on guinea-pig ileum again found relaxant activity on smooth muscle.

So the pharmacological record supports the statement “raspberry leaf extracts affect smooth muscle in a dish.” It does not support “raspberry leaf tones the uterus.” The tradition resolved the contradiction by adopting a word — tonic — elastic enough to mean relaxation and stimulation simultaneously, whichever the situation seems to require. A drug that both relaxes and strengthens a muscle depending on need would be remarkable; the more ordinary explanation is that different extracts of a tannin-rich leaf, applied to different tissues in different states, produce different results, and that none of it was measured in a pregnant human uterus at term.

Two further caveats worth stating. First, these were extracts, often alcoholic or concentrated, applied directly to tissue — not a cup of infusion crossing a gut wall, surviving first-pass metabolism and reaching the myometrium. Second, the alkaloid content of raspberry leaf is low and variable, and fragarine has never been characterised pharmacologically the way a drug candidate would be. It is a name that carries more authority in herbal writing than it has earned in pharmacology.

The 1999 Retrospective Study

Evidence tier: observational, retrospective — hypothesis-generating only.

Parsons, Simpson and Ponton published “Raspberry leaf and its effect on labour: safety and efficacy” in the Australian College of Midwives Incorporated Journal in 1999. They looked back at the records of women who had given birth at an Australian hospital and compared those who had taken raspberry leaf with those who had not — on the order of a hundred women per group. Their report suggested that the raspberry-leaf group tended to have shorter labours and fewer interventions, and it found no evidence of harm.

The design is the problem, and it is not a small one. Women were not assigned to raspberry leaf; they chose it. Women who choose a herbal pregnancy tea differ systematically from women who do not — in antenatal education, in planned place and mode of birth, in attitude to epidural and to intervention, often in parity and in who their care provider is. Any of those differences could produce a shorter recorded labour with fewer forceps without the tea doing anything whatsoever. This is the same confounding that made decades of observational nutrition findings evaporate in trials.

A retrospective study of this kind has one legitimate use: it justifies running a proper trial. To their credit, that is exactly what the same group did next.

The 2001 Randomized Double-Blind Trial

Evidence tier: randomized controlled trial — single, small, and the best evidence that exists.

Simpson, Parsons, Greenwood and Wade published “Raspberry leaf in pregnancy: its safety and efficacy in labor” in the Journal of Midwifery & Women’s Health in 2001. Low-risk women expecting their first baby were randomized in the last weeks of pregnancy — from around 32 weeks — to raspberry leaf tablets or to an identical placebo, taken twice daily until labour. Neither the women nor the staff knew which they were receiving. Roughly 190 women were enrolled.

The findings, as plainly as they can be put:

No significant difference in the first stage of labour. This was the primary interest and the longest stage, and it is the stage the tradition claims to improve. Nothing.
A modest shortening of the second stage — the pushing stage — in the raspberry-leaf group, reported as a difference of minutes rather than hours.
Fewer forceps deliveries in the raspberry-leaf group.
No significant difference in most other outcomes, including caesarean rate and the condition of the babies.
No harm to mothers or babies was observed.

How much weight should the second and third points carry? Less than the internet gives them. They were secondary outcomes in a single trial of under 200 women. In a trial that size, with many outcomes measured, one or two differences reaching statistical significance by chance is expected rather than surprising. Second-stage duration in particular is highly sensitive to obstetric practice — when a clinician decides to intervene — and the forceps finding is not independent of it: if a labour is allowed to proceed a little longer, forceps are used a little less, and both numbers move together for reasons that have nothing to do with tea.

None of this means the herb does nothing. It means that after the only randomized trial ever conducted, the honest conclusion is that no clear benefit was demonstrated, with a hint on secondary measures that would need a trial several times larger to confirm or bury. That trial has never been run. Twenty-five years later, this is still the whole clinical evidence base.

What the Systematic Reviews Concluded

Independent reviewers have looked at exactly the same two studies and reached the same verdict.

Holst, Haavik and Nordeng asked the question directly in the title of their 2009 paper in Complementary Therapies in Clinical Practice: “Raspberry leaf — should it be recommended to pregnant women?” Their answer was that the documentation is too limited to recommend it, and they noted that the herb’s popularity rests on tradition rather than on data.

Bowman, Taylor, Muggleton and Davis published a systematic integrative review, “Biophysical effects, safety and efficacy of raspberry leaf use in pregnancy,” in BMC Complementary Medicine and Therapies in 2021. Their conclusion, in substance: the evidence is insufficient to support the claimed benefits, the safety data are limited but do not show a clear signal of harm, and better research is needed before raspberry leaf can be recommended or ruled out. Broader reviews of herbal medicine in pregnancy — Dante and colleagues in Current Opinion in Obstetrics & Gynecology in 2014, and Muñoz Balbontín and colleagues in Obstetrics & Gynecology in 2019 — place raspberry leaf in the same category: commonly used, poorly evidenced, no established serious harm, insufficient basis for a recommendation.

It is worth appreciating what a consistent picture this is. Reviewers with no stake in the outcome, working a decade apart, all land on insufficient evidence. That is not a fashionable scepticism; it is what two studies from one group in one city support.

It Is Not a Labour Induction Method

Evidence tier: not supported by any study.

This section exists because the belief is widespread and because acting on it can cause real harm.

Nothing in the literature shows raspberry leaf starts labour. It has never been tested as an induction agent, no trial has found it triggers contractions, and the pharmacology — which, remember, leans relaxant as often as stimulant — gives no reason to expect it would. Ripening a cervix and initiating labour is a coordinated hormonal cascade involving prostaglandins, oxytocin receptor upregulation and gap-junction formation. A dilute infusion of a tannin-rich leaf is not a plausible trigger for it.

The specific harms of believing otherwise:

Delay. A person 41 weeks and 5 days pregnant who drinks four cups a day for a week instead of attending a post-dates appointment has traded monitoring for a placebo. Post-dates pregnancy is monitored for good reasons.
Escalation. “It is not working, so I will take more” leads to very strong infusions or handfuls of capsules, which is where the mild laxative and diuretic effects of a tannin-heavy preparation stop being trivial — diarrhoea and dehydration are not what anyone needs entering labour.
Dangerous company. Raspberry leaf is often bundled in online induction protocols with genuinely risky items — high-dose castor oil, blue cohosh, evening primrose oil inserted vaginally, black cohosh. Blue cohosh in particular has case reports of serious neonatal harm. The tea itself is the mildest thing on those lists, and the lists are the hazard.
Misreading a warning. Someone convinced that a tea can start labour may interpret genuine preterm contractions as “it working.” Regular contractions before 37 weeks are a reason to call your maternity unit immediately.

If a pregnancy needs to be moved along, that is a clinical decision with monitored methods behind it. See Preterm Labor for why the timing of contractions matters so much.

Safety in Pregnancy: Known, Assumed, and Unknown

The fair summary is reassuring, not established. Millions of cups have been drunk over generations without an obvious pattern of disaster, and the randomized trial saw no harm to mothers or babies. That is meaningful. It is also not a safety database: fewer than 200 women in one trial cannot detect an uncommon harm, and traditional use is not surveillance — it records what people did, not what happened to them.

The specific points that matter, each with its actual basis:

Most midwifery guidance suggests avoiding it in the first trimester. The basis is caution rather than data: if the herb acts on the uterus at all, early pregnancy is not when you want to find out. There is no trial of first-trimester use, which is itself the argument for not being the test case. Traditional practice starts it in the third trimester, commonly around 32 weeks.
A history of preterm labour, or any current risk of it, is a reason not to self-start. Same logic, higher stakes.
Planned caesarean. If the plan is not to labour, there is no benefit even on the traditional theory, and any possibility of uterine activity before a scheduled operation is unwanted. Ask your team.
Diabetes and gestational diabetes. A 2016 case report in Obstetrics & Gynecology by Cheang and colleagues described hypoglycaemia in a woman with gestational diabetes using raspberry leaf, and animal work suggests Rubus leaf preparations can lower blood glucose. One case report is the weakest design there is — but combined with the animal data it is enough to say: if you are on insulin or a glucose-lowering medication, mention the tea and watch your readings. See Gestational Diabetes.
Iron. The leaf’s tannins bind non-haem iron and reduce its absorption, and pregnancy raises iron requirements substantially. Drink it between meals rather than with an iron-rich meal or an iron tablet. See Iron-Deficiency Anemia and Iron.
Mild laxative and diuretic potential. Real, dose-related, and usually irrelevant at one or two cups — but a reason not to escalate.
Hormone-sensitive conditions. A theoretical caution rather than a demonstrated effect, but shared with several “women’s herbs” and worth raising with a clinician.
Product quality. Bulk dried herb is a loosely regulated commodity. Mislabelling and contamination happen, and the tea is not a pharmaceutical with a guaranteed content.

Animal Data and the Offspring Question

Evidence tier: preliminary (animal).

One study deserves naming because it is the main reason a careful writer will not say raspberry leaf is simply safe. Johnson, Makaji, Ho, Xiong, Crankshaw and Holloway published “Effect of maternal raspberry leaf consumption in rats on pregnancy outcome and the fertility of the female offspring” in Reproductive Sciences in 2009 — a rat study looking not just at the pregnancy but at the reproductive development of the female pups.

Rat studies translate to humans unreliably; doses are often far above what a person consumes, and rodent reproductive physiology is not human reproductive physiology. This study should not frighten anyone off a cup of tea. What it does establish is that the question “does prenatal exposure affect the offspring later?” has been asked, has produced findings worth following up, and has never been followed up in humans. When somebody says raspberry leaf is “proven safe in pregnancy,” that is the gap they are talking over.

If You Are Going to Drink It Anyway

Plenty of readers will finish this page and still want the tea, and that is a legitimate choice for a mild traditional drink in a straightforward third-trimester pregnancy. Practical points, in order of usefulness:

Tell your midwife or doctor. One sentence at your next appointment: “I’m drinking raspberry leaf tea — any reason not to?” Most will say fine. Some will have a specific reason in your case, and that reason is the entire value of asking. Surveys consistently find most women never mention herbal use at all.
Start in the third trimester, not before — traditional practice is from around 32 weeks.
Start with one cup a day and only build up if it agrees with you. There is no evidence-based dose to reach; more is not better, and the dosing page explains the ceiling.
Prefer the tea to capsules and tinctures, which are more concentrated and much less like anything ever studied.
Drink it away from iron-rich meals and iron tablets.
Expect nothing in particular. Genuinely the most useful instruction on this page. If you expect a warm drink and a small ritual in the evenings, you will get it. If you expect a shorter labour, the only trial that looked did not find one.
Stop and call your maternity unit, rather than reasoning about the tea, if you have regular contractions before 37 weeks, any bleeding, fluid loss, or reduced fetal movement.

Evidence Tiers at a Glance

Randomized clinical trial: no significant effect on first-stage labour; modest secondary findings on second-stage duration and forceps use in one trial of roughly 190 women; no harm observed.
Observational: one retrospective study suggesting shorter labour and fewer interventions, with confounding that cannot be excluded.
Preliminary (in vitro / animal): smooth-muscle effects in isolated tissue, direction inconsistent; rat data on pregnancy outcome and offspring fertility; animal glucose-lowering.
Traditional use only: uterine “toning,” easier birth, reduced postpartum bleeding, postpartum recovery.
Insufficient evidence: every headline benefit claim, per two independent reviews.
Not supported: labour induction.

Back to Table of Contents

Key Research Papers

Each entry names the paper and links a PubMed search rather than a numeric identifier, so you can confirm for yourself that the description matches the paper.

Simpson M, Parsons M, Greenwood J, Wade K. “Raspberry leaf in pregnancy: its safety and efficacy in labor.” Journal of Midwifery & Women’s Health, 2001 — the only randomized, double-blind, placebo-controlled trial. Search PubMed
Parsons M, Simpson M, Ponton T. “Raspberry leaf and its effect on labour: safety and efficacy.” Australian College of Midwives Incorporated Journal, 1999 — the retrospective study that preceded it. Search PubMed
Holst L, Haavik S, Nordeng H. “Raspberry leaf — should it be recommended to pregnant women?” Complementary Therapies in Clinical Practice, 2009 — concludes the documentation is too limited. Search PubMed
Bowman R, Taylor J, Muggleton S, Davis D. “Biophysical effects, safety and efficacy of raspberry leaf use in pregnancy: a systematic integrative review.” BMC Complementary Medicine and Therapies, 2021. Search PubMed
Burn JH, Withell ER. “A principle in raspberry leaves which relaxes uterine muscle.” The Lancet, 1941 — the relaxant finding at the root of the mechanism story. Search PubMed
Whitehouse B. “Fragarine: an inhibitor of uterine action.” British Medical Journal, 1941 — fragarine described as inhibitory, not tonic. Search PubMed
Bamford DS and colleagues on raspberry leaf and uterine smooth muscle, British Journal of Pharmacology, 1970 — effect direction depends on preparation and tissue state. Search PubMed
Relaxant activity of Rubus idaeus leaf extract on isolated smooth muscle, Phytotherapy Research, 2002. Search PubMed
Johnson JR, Makaji E, Ho S, Xiong B, Crankshaw DJ, Holloway AC. “Effect of maternal raspberry leaf consumption in rats on pregnancy outcome and the fertility of the female offspring.” Reproductive Sciences, 2009. Search PubMed
Cheang KI, Nguyen TT, Karjane NW, Salley KE. “Raspberry leaf and hypoglycemia in gestational diabetes mellitus.” Obstetrics & Gynecology, 2016 — single case report behind the diabetes caution. Search PubMed
Holst L, Wright D, Haavik S, Nordeng H. “The use and the user of herbal remedies during pregnancy.” The Journal of Alternative and Complementary Medicine, 2009 — how common the practice is, and how rarely it is disclosed. Search PubMed
Muñoz Balbontín Y, Stewart D, Shetty A, Fitton CA, McLay JS. “Herbal medicinal product use during pregnancy and the postnatal period: a systematic review.” Obstetrics & Gynecology, 2019. Search PubMed
Dante G, Bellei G, Neri I, Facchinetti F. “Herbal therapies in pregnancy: what works?” Current Opinion in Obstetrics & Gynecology, 2014. Search PubMed
Cochrane reviews of methods used to induce labour — useful context for what an intervention with real evidence looks like. Search PubMed

Back to Table of Contents

Connections

This page is information, not antenatal advice. It describes published research about a traditional herbal tea; it is not a treatment recommendation, not a dosing instruction from a clinician, and not a substitute for care from your midwife, obstetrician or physician — who knows your pregnancy, and this page does not. Do not use raspberry leaf to try to bring on labour. If your pregnancy is high-risk, you have a history of preterm labour, you have a planned caesarean, or you take medication for diabetes or blood clotting, speak to your care team before using it. Contact your maternity unit immediately — not a tea — for contractions before 37 weeks, bleeding, fluid loss, severe headache or visual changes, or reduced fetal movement.

Back to Table of Contents